Taking Stock
OPKO's Bishop on FDA Approval Of Its Kidney Disease Drug(Audio)
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:08:45
- Mais informações
Informações:
Sinopse
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Dr. Charles Bishop, CEO of OPKO Health Renal Division, to discuss the FDA’s approval of Rayaldee and the health issues surrounding chronic kidney disease
